Aurobindo Pharma Q3 Results: Net profit drops 19% YoY to Rs 491 crore
We witnessed an improved momentum backed by recovery across our business verticals and our endeavor is to continuously innovate and differentiate," said K. Nithyananda Reddy, vice-chairman and managing director of Aurobindo Pharma
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
